MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Intuitive Surgical Inc

Open

SectorGezondheidszorg

509.21 1.09

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

503.3

Max

513.24

Belangrijke statistieken

By Trading Economics

Inkomsten

123M

688M

Verkoop

374M

2.4B

K/W

Sectorgemiddelde

72.947

57.333

EPS

2.21

Winstmarge

28.506

Werknemers

15,638

EBITDA

116M

810M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+16.53% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-39B

168B

Vorige openingsprijs

508.12

Vorige sluitingsprijs

509.21

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Intuitive Surgical Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 apr 2025, 20:55 UTC

Winsten

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23 jan 2025, 21:41 UTC

Winsten

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21 jan 2025, 18:37 UTC

Acquisities, Fusies, Overnames

Intuitive to Establish Direct Presence in Europe With Acquisition

18 okt 2024, 15:22 UTC

Winsten
Belangrijke Marktbewegers

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17 okt 2024, 21:33 UTC

Winsten
Belangrijke Marktbewegers

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17 okt 2024, 20:56 UTC

Winsten

Intuitive Surgical Posts 3Q Revenue Growth

22 apr 2025, 20:13 UTC

Winsten

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q EPS $1.92 >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Net $698.4M >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22 apr 2025, 20:05 UTC

Winsten

Intuitive Surgical 1Q Rev $2.25B >ISRG

24 jan 2025, 21:17 UTC

Winsten

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24 jan 2025, 18:18 UTC

Winsten

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24 jan 2025, 13:11 UTC

Top Nieuws

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24 jan 2025, 09:51 UTC

Populaire aandelen

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23 jan 2025, 21:10 UTC

Winsten

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23 jan 2025, 21:09 UTC

Winsten

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23 jan 2025, 21:09 UTC

Winsten

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23 jan 2025, 21:05 UTC

Winsten

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23 jan 2025, 21:05 UTC

Winsten

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23 jan 2025, 21:05 UTC

Winsten

Intuitive Surgical 4Q Rev $2.41B >ISRG

23 jan 2025, 21:05 UTC

Winsten

Intuitive Surgical 4Q Net $685.7M >ISRG

23 jan 2025, 21:05 UTC

Winsten

Intuitive Surgical 4Q EPS $1.88 >ISRG

15 jan 2025, 17:27 UTC

Winsten

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6 jan 2025, 12:00 UTC

Top Nieuws

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18 okt 2024, 15:59 UTC

Winsten

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18 okt 2024, 15:38 UTC

Winsten

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18 okt 2024, 13:28 UTC

Winsten

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17 okt 2024, 21:18 UTC

Winsten
Belangrijke Marktbewegers

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

Peer Vergelijking

Prijswijziging

Intuitive Surgical Inc Prognose

Koersdoel

By TipRanks

16.53% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 592.13 USD  16.53%

Hoogste 675 USD

Laagste 470 USD

Gebaseerd op 18 Wall Street-analisten die 12-maands prijsdoelen bieden voor Intuitive Surgical Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

18 ratings

15

Buy

3

Hold

0

Sell

Technische score

By Trading Central

489.52 / 517.31Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Weak Bullish Evidence

Lange Termijn

Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.